본문 바로가기
KERD
논문KCI 등재

The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients

최효영|신은경|Hayes Neil
한국역학회 (Korean Society of Epidemiology)|2021.01|Epidemiology and Health|제43권 |pp. 1-8|DOI 10.4178/epih.e2021035

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

COVID-19KoreaSocial network analysisComorbidityInfectious diseaseSymptoms

초록

OBJECTIVES: We aimed to examine how comorbidities were associated with outcomes (illness severity or death) among hospitalized patients with coronavirus disease 2019 (COVID-19).METHODS: Data were provided by the National Medical Center of the Korea Disease Control and Prevention Agency. These data included the clinical and epidemiological information of all patients hospitalized with COVID-19 who were discharged on or before April 30, 2020 in Korea. We conducted comorbidity network and multinomial logistic regression analyses to identify risk factors associated with COVID-19 disease severity and mortality. The outcome variable was the clinical severity score (CSS), categorized as mild (oxygen treatment not needed), severe (oxygen treatment needed), or death.RESULTS: In total, 5,771 patients were included. In the fully adjusted model, chronic kidney disease (CKD) (odds ratio [OR], 2.58; 95% confidence interval [CI], 1.19 to 5.61) and chronic obstructive pulmonary disease (COPD) (OR, 3.19; 95% CI, 1.35 to 7.52) were significantly associated with disease severity. CKD (OR, 5.35; 95% CI, 2.00 to 14.31), heart failure (HF) (OR, 3.15; 95% CI, 1.22 to 8.15), malignancy (OR, 3.38; 95% CI, 1.59 to 7.17), dementia (OR, 2.62; 95% CI, 1.45 to 4.72), and diabetes mellitus (OR, 2.26; 95% CI, 1.46 to 3.49) were associated with an increased risk of death. Asthma and hypertension showed statistically insignificant associations with an increased risk of death.CONCLUSIONS: Underlying diseases contribute differently to the severity of COVID-19. To efficiently allocate limited medical resources, underlying comorbidities should be closely monitored, particularly CKD, COPD, and HF.

Abstract

OBJECTIVES: We aimed to examine how comorbidities were associated with outcomes (illness severity or death) among hospitalized patients with coronavirus disease 2019 (COVID-19).METHODS: Data were provided by the National Medical Center of the Korea Disease Control and Prevention Agency. These data included the clinical and epidemiological information of all patients hospitalized with COVID-19 who were discharged on or before April 30, 2020 in Korea. We conducted comorbidity network and multinomial logistic regression analyses to identify risk factors associated with COVID-19 disease severity and mortality. The outcome variable was the clinical severity score (CSS), categorized as mild (oxygen treatment not needed), severe (oxygen treatment needed), or death.RESULTS: In total, 5,771 patients were included. In the fully adjusted model, chronic kidney disease (CKD) (odds ratio [OR], 2.58; 95% confidence interval [CI], 1.19 to 5.61) and chronic obstructive pulmonary disease (COPD) (OR, 3.19; 95% CI, 1.35 to 7.52) were significantly associated with disease severity. CKD (OR, 5.35; 95% CI, 2.00 to 14.31), heart failure (HF) (OR, 3.15; 95% CI, 1.22 to 8.15), malignancy (OR, 3.38; 95% CI, 1.59 to 7.17), dementia (OR, 2.62; 95% CI, 1.45 to 4.72), and diabetes mellitus (OR, 2.26; 95% CI, 1.46 to 3.49) were associated with an increased risk of death. Asthma and hypertension showed statistically insignificant associations with an increased risk of death.CONCLUSIONS: Underlying diseases contribute differently to the severity of COVID-19. To efficiently allocate limited medical resources, underlying comorbidities should be closely monitored, particularly CKD, COPD, and HF.

참고문헌 (37)

  1. Paules CI, "Coronavirus infections-more than just the common cold", JAMA, 323, pp.707~708 (2020)
  2. Fauci AS, "Covid-19-navigating the uncharted", N Engl J Med, 382, pp.1268~1269 (2020)
  3. "Estimating mortality from COVID-19" (2020)[URL]
  4. "Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update"[URL]
  5. Wang X, "Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis", Research(Wash D C), 2020, pp.2402961~ (2020)
  6. Wadhera RK, "Variation in COVID-19 hospitalizations and deaths across New York City boroughs", JAMA, 323, pp.2192~2195 (2020)
  7. Richardson S, "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19in the New York City area", JAMA, 323, pp.2052~2059 (2020)
  8. Livingston E, "Coronavirus disease 2019(COVID-19)in Italy", JAMA, 323, pp.1335~ (2020)
  9. Kashnitsky I, "COVID-19 in unequally ageing European regions", World Dev, 136, pp.105170~ (2020)
  10. Wang H, "Risk of COVID-19 for patients with cancer", Lancet Oncol, 21, pp.e181~ (2020)
  11. Ji Y, "Potential association between COVID-19 mortality and health-care resource availability", Lancet Glob Health, 8, pp.e480~ (2020)
  12. Wu C, "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China", JAMA Intern Med, 180, pp.934~943 (2020)
  13. Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
  14. Wu Z, "Characteristics of and important lessons from the coronavirus disease 2019(COVID-19)outbreak in China : summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention", JAMA, 323, pp.1239~1242 (2020)
  15. Guan WJ, "Comorbidity and its impact on 1590 patients with COVID-19 in China : a nationwide analysis", Eur Respir J, 55, pp.2000547~ (2020)
  16. Cramer AO, "Comorbidity : a network perspective", Behav Brain Sci, 33, pp.137~150 (2010)
  17. Lee DS, "The implications of human metabolic network topology for disease comorbidity", Proc Natl Acad Sci U S A, 105, pp.9880~9885 (2008)
  18. Yang J, "Prevalence of comorbidities in the novel Wuhan coronavirus(COVID-19)infection : a systematic review and meta-analysis", Int J Infect Dis, 94, pp.91~95 (2020)
  19. Sanyaolu A, "Comorbidity and its impact on patients with COVID-19", SN Compr Clin Med, pp.1~8 (2020)
  20. Zhu L, "Association of blood glucose control and outcomes in patients with COVID19 and pre-existing type 2 diabetes", Cell Metab, 31, pp.1068~1077 (2020)
  21. Atkins JL, "Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort", J Gerontol A Biol Sci Med Sci, 75, pp.2224~2230 (2020)
  22. Ji Wonjun, "Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study", Journal of Korean Medical Science, 35(25), pp.1~15 (2020), 대한의학회[DOI]
  23. Targher G, "Patients with diabetes are at higher risk for severe illness from COVID-19", Diabetes Metab, 46, pp.335~337 (2020)
  24. Singh AK, "Diabetes in COVID-19 : prevalence, pathophysiology, prognosis and practical considerations", Diabetes Metab Syndr, 14, pp.303~310 (2020)
  25. Singh AK, "Comorbidities in COVID-19 : outcomes in hypertensive cohort and controversies with renin angiotensin system blockers", Diabetes Metab Syndr, 14, pp.283~287 (2020)
  26. Liang W, "Cancer patients in SARS-CoV-2 infection : a nationwide analysis in China", Lancet Oncol, 21, pp.335~337 (2020)
  27. Schiffrin EL, "Hypertension and COVID-19", Am J Hypertens, 33, pp.373~374 (2020)
  28. Jordan RE, "Covid-19: risk factors for severe disease and death", BMJ, 368, pp.m1198~ (2020)
  29. Shahid Z, "COVID-19 and older adults : what we know", J Am Geriatr Soc, 68, pp.926~929 (2020)
  30. Shin EK, "Applied network science for relational chronic disease surveillance", Stud Health Technol Inform, 262, pp.336~339 (2019)
  31. Borgatti SP, "Network analysis of 2-mode data", Soc Networks, 19, pp.243~269 (1997)
  32. Soper HE, "On the distribution of the correlation coefficient in small samples. Appendix II to the papers of"Student"and RA Fisher", Biometrika, 11, pp.328~413 (1917)
  33. Hilbe JM, "Logistic regression models", pp.385~398 (2009), CRC Press
  34. Hosmer DW, "Applied logistic regression", pp.369~311 (2013), John Wiley & Sons
  35. Agresti A, "Categorical data analysis", pp.267~282 (2003), John Wiley &Sons
  36. Dietz W, "Obesity and its implications for COVID-19 mortality", Obesity(Silver Spring), 28, pp.1005~ (2020)
  37. Shin EK, "Geo-clustered chronic affinity : pathways from socio-economic disadvantages to health disparities", JAMIA Open, 2, pp.317~322 (2019)

관련 논문AI추천

Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-AnalysisHoang Tung, Tran Thi Anh Tho대한감염학회 · Infection and Chemotherapy2021 · 제53권 제1호Predictors of Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis김우림, 이경은, 한지민한국임상약학회 · 한국임상약학회지2020 · 제30권 제3호New Scoring System for Predicting Mortality in Patients with COVID-19권기태, 김신우, 김윤정, 배소현, 장현하, 황소윤연세대학교의과대학 · Yonsei Medical Journal2021 · 제62권 제9호한국 코로나바이러스감염증-19 환자 5,628명의 역학적, 임상적 특성: 전국단위 다기관 관찰 연구문성용, 연동건, 이승원대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2021 · 제9권 제3호Analysis of Risk Factors for Severe Acute Respiratory Infection and Pneumonia and among Adult Patients with Acute Respiratory Illness during 2011-2014 Influenza Seasons in Korea강성희, 김신우, 김영근, 김우주, 노지윤, 박경화, 서유빈, 송준영, 위성헌, 이선희, 이재갑, 이진수, 전지호, 정은주, 정혜원, 정희진, 최민주, 최원석대한감염학회 · Infection and Chemotherapy2016 · 제48권 제4호Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)?Alvanegh Akbar Ghorbani, Ataee Mohammad Reza, Bagheri Mehdi, Bahardoust Mansour, Goharrizi Mohammad Ali Sheikh Beig, Heiat Mohammad, Navidiyan Ensiyeh Shabani, Zijoud Seyed Reza Hosseini대한고혈압학회 · Clinical Hypertension2021 · 제27권 제2호

이 간행물의 다른 논문 (102건)

Trends in the prevalence and management of major metabolic risk factors for chronic disease over 20 years: Findings from the 1998–2018 Korea National Health and Nutrition Examination Survey김영택, Kim Hyejin, Park Suyeon, 오경원, Park Ok, Yoonjung Kim, Nho Sun Jin, Woo Gyeongjipp. 1-12Letter to the Editor: Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims최용준pp. 1-2Impact of early-life weight status on urinary tract infection in children: a nationwide population-based study in South Korea김봉성, 유기환, Han Kyung-do, Hyung Eun Yimpp. 1-9Trends in food and nutrient intake over 20 years: findings from the 1998-2018 Korea National Health and Nutrition Examination Survey김영택, 오경원, Park Jin Young, Park Suyeon, Yun Sungha, Kim Yangha, Yang Ji Eun, Park Ok, Sanghui Kweon, Park Myungsook, Yeon So Yeong, Yoon Leenapp. 1-9Trends in health behaviors over 20 years : Findings from the 1998-2018 Korea National Health and Nutrition Examination Survey김영택, 최선혜, Jihee Kim, Park Suyeon, 오경원, Park Ok, 김소연pp. 1-12
원문 보기